Aneurysm treatment with pushable implanted braid

Information

  • Patent Grant
  • 11497504
  • Patent Number
    11,497,504
  • Date Filed
    Monday, April 20, 2020
    4 years ago
  • Date Issued
    Tuesday, November 15, 2022
    2 years ago
Abstract
The present invention provides a braided implant with a retractable dual proximal layer and methods for administering the braided implant to treat aneurysms. The implant can include a tubular braid that can be set into a predetermined shape, compressed for delivery through a microcatheter, and implanted in at least one implanted position that is based on the predetermined shape and the geometry of the aneurysm in which the braid is implanted. The implant can also have a retractable dual layer at the proximal end of the device made of the same braid to provide additional coverage at the neck of the aneurysm. The dual layer can be pressed distally into a first implanted portion of the tubular braid, moving the first portion of the tubular braid towards the distal portion of an aneurysm wall so that the implant can partially or completely occlude an aneurysm neck.
Description
FIELD OF THE INVENTION

The present invention generally relates to medical instruments, and more particularly, to embolic implants for aneurysm therapy.


BACKGROUND

Aneurysms can be complicated and difficult to treat. For example, treatment access may be limited or unavailable when an aneurysm is located proximate critical tissues. Such factors are of particular concern with cranial aneurysms due to the brain tissue surrounding cranial vessels and the corresponding limited treatment access.


Prior solutions have included endovascular treatment access whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow. In this respect, because the interior walls of the aneurysm may continue being subjected to flow of blood and related pressure, aneurysm rupture remains possible.


Alternative to endovascular or other surgical approaches can include occlusive devices. Such devices have typically incorporated multiple embolic coils that are delivered to the vasculature using microcatheter delivery systems. For example, when treating cranial aneurysms, a delivery catheter with embolic coils is typically first inserted into non-cranial vasculature through a femoral artery in the hip or groin area. Thereafter, the catheter is guided to a location of interest within the cranium. The sac of the aneurysm can then be filled with the embolic material to create a thrombotic mass that protects the arterial walls from blood flow and related pressure. However, such occlusive devices do have certain shortcomings, including mass effect, which can cause compression on the brain and its nerves.


For example, embolic coils delivered to the neck of the aneurysm can potentially have the adverse effect of impeding the flow of blood in the adjoining blood vessel, particularly if the entrance is overpacked. Conversely, if the entrance is insufficiently packed, blood flow can persist into the aneurysm. Treating certain aneurysm morphology (e.g. wide neck, bifurcation, etc.) can require ancillary devices such a stents or balloons to support the coil mass and obtain the desired packing density. Once implanted, the coils cannot easily be retracted or repositioned. Furthermore, embolic coils do not always effectively treat aneurysms as aneurysms treated with multiple coils often recanalize or compact because of poor coiling, lack of coverage across the aneurysm neck, blood flow, or large aneurysm size.


Another particular type of occlusive approach endeavors to deliver and treat the entrance or “neck” of the aneurysm. In such “neck” approaches, by minimizing blood flow across the neck, a cessation of flow into the aneurysm may be achieved. It is understood that the neck plane is an imaginary surface where the inner most layer of the parent wall would be but for the aneurysm. However, neck-occlusive approaches, such as implanting a flow impeding device in the parent vessel, are not without drawbacks. Such an approach may impede blood flow into peripheral blood vessels while blocking the aneurysm neck in the parent vessel. Impeding flow to the peripheral blood vessel can unintentionally lead to severe damage if the openings of the vessels are blocked.


Alternatives to embolic coils are being explored, such as tubular braided implants. Tubular braided implants have the potential to easily, accurately, and safely treat an aneurysm or other arterio-venous malformation in a parent vessel without blocking flow into perforator vessels communicating with the parent vessel. Compared to embolic coils, however, tubular braided implants are a newer technology, and there is therefore capacity for improved geometries, configurations, delivery systems, etc. for the tubular braided implants. For instance, delivery of tubular braided implants can require unique delivery systems to prevent the braid from inverting or abrading when pushed through a microcatheter, and some simple delivery systems that push embolic coils through microcatheters from their proximal end may not be effective to deliver tubular braids.


There is therefore a need for improved methods, devices, and systems for implants for aneurysm treatment.


SUMMARY

It is an object of the present invention to provide systems, devices, and methods to meet the above-stated needs. Generally, it is an object of the present invention to provide a braided implant with a retractable dual proximal layer. The implant can secure within an aneurysm sac and occlude at least a majority of the aneurysm's neck. The implant can include a tubular braid that can be set into a predetermined shape, compressed for delivery through a microcatheter, and implanted in at least one implanted position that is based on the predetermined shape and the geometry of the aneurysm in which the braid is implanted. The implant can also have a retractable dual layer at the proximal end of the device made of the same braid to provide additional coverage at the neck of the aneurysm.


In some examples presented herein, the dual layer can be shaped by expanding it radially, and the dual layer can be pressed distally into a first portion of the tubular braid already within the aneurysm. By pressing the dual layer distally into the first portion of the tubular braid, the first portion of the tubular braid can be moved towards the distal portion of an aneurysm wall so that the implant can partially or completely occlude an aneurysm neck. Pushing the dual layer into the first portion of the braid can help conform the implant to the shape of the aneurysm and resist compaction. The dual layer when expanded radially and pressed into the first portion of the braid also can provide additional coverage at the neck of the aneurysm to increase thrombosis. In some examples, the dual layer can also be placed within the aneurysm sac with only a detachment point external to the sac.


In some examples, the tubular braid can include memory shape material that can be heat set to a predetermined shape, can be deformed for delivery through a catheter, and can self-expand to an implanted shape that is based on the predetermined shape and confined by the anatomy of the aneurysm in which it is implanted.


In some examples the tubular braid can be shaped to a delivery shape that is extended to a single layer of tubular braid having a compressed circumference/diameter sized to be delivered through the microcatheter.


In some examples, before the implant is released from the delivery system, the implant can be partially or fully retracted into the microcatheter and repositioned.


An example method for forming an occlusive device to treat an aneurysm can include one or more of the following steps presented in no particular order, and the method can include additional steps not included here. An implant with a tubular braid, an open end, and a pinched end can be selected. The tubular braid can be shaped to a predetermined shape. Shaping the tubular braid to a predetermined shape can also include further steps. These steps can include inverting the tubular braid to form a distal inversion. The tubular braid can also be inverted to form a proximal inversion by moving the open end over at least a portion of the braid. A first segment of the tubular braid extending between the open end and the proximal inversion can be shaped. A second segment of the tubular braid extending between the proximal inversion and the distal inversion can be shaped. The open end can be positioned to encircle the second segment. A third segment extending from the distal inversion to the proximal inversion can be shaped. The second segment can be positioned to surround the third segment. A fourth segment of the tubular braid extending from the third segment radially outward from a central axis to cross the proximal inversion can be shaped and can fold and converge at the pinched end. The fourth segment can be positioned near the neck of an aneurysm.


An example method for treating an aneurysm can include one or more of the following steps presented in no particular order, and the method can include additional steps not included here. A first portion of a tubular braided implant, which can have a tubular braid, an open end, and a pinched end, can be positioned within a sac of the aneurysm such that the first portion circumferentially apposes walls within the sac. The first portion can have one or more inversions. A second portion of the tubular braided implant can be expanded radially to occlude a majority of a neck of the aneurysm. The second portion can be pressed distally into the first portion. The first portion of the tubular braided implant can be moved toward a distal portion of the aneurysm wall as a result of pressing the second portion distally into the first portion.


In some examples, expanding the second portion of the tubular braided implant can include positioning a fold in the second segment to define a substantially circular perimeter of the second portion and compressing the second portion along a central axis of the tubular braided implant such that the second portion can have a substantially circular shape having an area and two layers of braid over a majority of the area of the substantially circular shape.


In some examples, positioning the first portion of the tubular braided implant can further include shaping the tubular braided implant to form a columnar post encircling a central axis of the tubular braided implant and extending a majority of a height of the first portion. In another example, positioning the first portion of the tubular braided implant can further involve positioning a proximal inversion near the neck of the aneurysm and positioning a distal inversion approximate the distal portion of the aneurysm wall. In another example, positioning the first portion of the tubular braided implant can further involve positioning the open end of the tubular braided implant to circumferentially appose the aneurysm wall, shaping a first segment of the tubular braid extending between the open end and the proximal inversion to appose at least a portion of a wall of the aneurysm within the aneurysm's sac, and shaping a second segment of the tubular braid such that the first segment provides an outwardly radial force in a plane defining a boundary between the aneurysm and blood vessel branches, the force sufficient to appose the first segment to walls of the aneurysm.


In some examples, pressing the second portion distally into the first portion can further involve pressing the second portion of the tubular braided implant against the proximal inversion in the first portion of the tubular braided implant.





BRIEF DESCRIPTION OF THE DRAWINGS

The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.



FIG. 1A is an illustration of an example implant having a tubular braid in a predetermined shape according to aspects of the present invention;



FIG. 1B is an illustration of the example implant with the tubular braid in a first implanted shape according to aspects of the present invention;



FIGS. 2A through 2I are illustrations of an implant having a tubular braid that expands to an implanted shape similar to as illustrated in FIG. 1B as the tubular braid exits a microcatheter according to aspects of the present inventions;



FIGS. 3A through 3B are flow diagrams for a method of forming an occlusive device to treat an aneurysm; and



FIGS. 4A through 4B are flow diagrams for a method for treating an aneurysm.





DETAILED DESCRIPTION

Examples presented herein generally include a braided implant that can secure within an aneurysm sac and occlude a majority of the aneurysm's neck. The implant can include a tubular braid that can be set into a predetermined shape, compressed for delivery through a microcatheter, and implanted in at least one implanted position that is based on the predetermined shape and the geometry of the aneurysm in which the braid is implanted. The implant can include a single layer of braid (e.g. a braid that can be extended to form a single layer tube) heat treated into multiple layers with retractable dual layer at the proximal end of the tubular braid. When compressed, the implant can be sufficiently short to mitigate friction forces produced when the implant is delivered unsheathed through the microcatheter.


A first portion of the tubular braid can be positioned in an aneurysm, after which the retractable dual layer can be deployed from the microcatheter and pushed onto the first portion of the tubular braid. This configuration provides three layers of braid at the neck of the aneurysm. The dual layer can potentially cover any gap between the first portion of implanted tubular braid and the aneurysm neck, and can potentially increase metal coverage, decrease porosity of the implant, and increase stasis and blood flow diversion at the neck of the aneurysm to promote the sealing and healing of the aneurysm compared a similarly shaped braided implant lacking the dual layer. The entire implant can be retractable until a desired position is achieved.



FIGS. 1A and 1B are illustrations of an example braided implant 100 that can have a predetermined shape as shown in FIG. 1A and a distinct implanted shape as illustrated in FIG. 1B. The implant 100 can treat a range of aneurysm sizes. The implant 100 can include a tubular braid 110 having an open end 114 and a pinched end 112. The implant 100 can include a connection and detachment feature 150 (referred to equivalently as “connection feature” and “detachment feature” herein) attached to the braid 110 at the pinched end 112. The pinched end 112 can include a marker band and/or soldered point with visibility, and/or the connection feature 150 can include radiopaque material. The tubular braid 110 can be formed in the predetermined shape (FIG. 1A), collapsed for delivery through a microcatheter, attached to a delivery system at connection feature 150, and implanted in an implanted shape such as the one shown in FIG. 1B.


Referring to FIG. 1A, when in the predetermined shape, the tubular braid 110 can include two inversions 122, 124, a pinched end 112, and an open end 114. The tubular braid 110 can include four segments, 142, 144, 146, and 152. The first segment 142 can extend from the open end 114 of the tubular braid 110 to a proximal inversion 122. The second segment 144 can be encircled by the open end 114 and extend from the proximal inversion 122 to a distal inversion 124. The third segment 146 can be surrounded by the second segment 144 and extend from the distal inversion 124 to the proximal inversion 122. The first segment 142, second segment 144, and third segment 146 can form the first portion of the tubular braid 110. The fourth segment 152 can extend from the third segment 146 radially outward from a central axis to cross the proximal inversion 122, fold, and converge at the pinched end 112. The fourth segment 152 can be partially encircled by the proximal inversion 122.


When in the predetermined shape, the tubular braid 110 can be substantially radially symmetrical about a central vertical axis. The detachment feature 150 is illustrated in FIG. 1A as a flat key that can be used with a mechanical delivery implant system (not pictured). The tubular braid 110 can be formed into the predetermined shape by first inverting the braid outwardly to separate the third segment 146 from the second segment 144 with a distal inversion 124. Then, the second segment 144 can be shaped over a form to produce the substantially “S” shaped profile illustrated in FIG. 1A. Next, the braid 110 can be inverted outwardly again to separate the second segment 144 from the first segment 142 with a proximal inversion 122. Finally, the fourth segment 152 can be shaped by expanding the fourth segment 152 radially. The fourth segment 152 can be pressed distally into the first portion of the tubular braid 110. It can also be advantageous to minimize a neck opening 126 defined by the lower extension of the “S” shape of second segment 144 to maximize occlusion of an aneurysm neck when the implant 100 is implanted.


The tubular braid 110 can include memory shape material that can be heat set to a predetermined shape, can be deformed for delivery through a catheter, and can self-expand to an implanted shape that is based on the predetermined shape and confined by the anatomy of the aneurysm in which it is implanted. When the tubular braid 110 is in the predetermined shape as depicted in FIG. 1A, the fourth segment 152 can comprise a diameter D1 greater than or approximately equal to a maximum diameter D2 of the first segment 142. Alternatively, when the tubular braid 110 is in the predetermined shape as depicted in FIG. 1A, the fourth segment 152 can comprise a diameter D1 lesser than a maximum diameter D2 of the first segment 142. When the tubular braid 110 is in the predetermined shape (FIG. 1A), the second segment 144 can form a sack, and at least a portion of the third segment 146 can positioned within the sack and at least a portion of the fourth segment 152 can be positioned external to the sack. As illustrated (FIG. 1B), when implanted, the fourth segment 152 can be positioned external to the aneurysm sac, extending across the aneurysm neck 16. Preferably, the fourth segment 152 can appose vasculature walls surrounding the aneurysm neck 16 when implanted. Alternatively, the shaped fourth segment 152 can also be placed within the aneurysm sac. The detachment feature 150 can be implanted centrally in the aneurysm neck 16. The detachment feature 150 can be positioned external to the sac 12.


The tubular braid 110 in the implanted shape (FIG. 1B) can be radially or vertically compressed or extended compared to the predetermined shape. As illustrated in FIG. 1B, when in the implanted shape, the braid 110 can have an outer layer 142a corresponding to the first segment 142 of the predetermined shape and positioned to contact an aneurysm wall 14 of the aneurysm 10, a proximal inversion 122a corresponding to the proximal inversion 122 of the predetermined shape and positioned to be placed approximate a neck 16 of the aneurysm 10, and a sack 144a corresponding to the second segment 144 of the predetermined shape and positioned to appose a portion of the aneurysm wall 14 of the aneurysm 10 and apposing the outer layer 142a. A distal inversion 124a can correspond to the distal inversion 124 of the predetermined shape, a third segment 146a can correspond to the third segment 146 in the predetermined shape. The braid 110 can also have a fourth segment 152a corresponding to the fourth segment 152 of the predetermined shape and extending from the third segment 146a radially outward from a central axis to cross the proximal inversion 122a, fold, and converge at the pinched end 112. As described in FIG. 1A, the fourth segment 152a can be pressed distally into the first portion of the tubular braid 110.


By pressing the fourth segment 152a distally into the first portion of the tubular braid 110, the first portion 142a, 144a, 146a of the tubular braid 110 can be moved towards the distal portion of an aneurysm wall 15 to occlude a portion of the neck 16 of the aneurysm 10. Pushing the fourth segment 152a into the first portion of the braid 110 can help conform the implant 100 to the shape of the aneurysm 10 and resist compaction. The fourth segment 152a when expanded radially and pressed into the first portion of the braid 110 also can provide additional coverage at the neck 16 of the aneurysm 10 to increase thrombosis and seal the aneurysm 10. When the fourth segment 152a is pressed into the first portion of the braid 110, three layers of braid are present at the neck of the aneurysm. The fourth segment 152a can cover spatial gaps between the first portion of implanted tubular braid 110 and the aneurysm neck 16, and can potentially increase metal coverage, decrease porosity of the implant 100, and increase stasis and blood flow diversion at the neck 16 of the aneurysm 10 to promote the sealing and thrombosis of the aneurysm 10. The fourth segment 152a can be shaped to occlude the majority of an aneurysm neck 16 when the device 100 is implanted. The fourth segment 152a can be shaped to completely occlude an aneurysm neck 16 when the device 100 is implanted.


When the tubular braid 110 is in the implanted shape (FIG. 1B), the fourth segment 152a can comprise a diameter D1 greater than or approximately equal to a maximum diameter D2 of the first segment 142a. Alternatively, when the tubular braid 110 is in the implanted shape (FIG. 1B), the fourth segment 152a can comprise a diameter D1 lesser than a maximum diameter D2 of the first segment 142a. When the tubular braid 110 is in the implanted shape (FIG. 1B), the second segment 144a can form a sack, and at least a portion of the third segment 146a can be positioned within the sack and at least a portion of the fourth segment 152a can be positioned external to the sack. The shaped fourth segment 152a can also be placed within the aneurysm sac 12 with only the detachment point 150 external to the sac 12.



FIGS. 2A through 2I are illustrations of an example implant 100 having a braid 110 expanding to an implanted shape that is based on a predetermined shape and the anatomy of the aneurysm and nearby blood vessel as the braid 110 exits a microcatheter 600. The implant 100 has a predetermined shape similar to the shape illustrated in FIG. 1A. As illustrated in FIG. 2A, the braid 110 can be shaped to a delivery shape that is extended to a single layer of tubular braid having a compressed circumference/diameter sized to be delivered through the microcatheter 600 and a length L. As will be appreciated and understood by a person of ordinary skill in the art, the length L of a specific braid 110 can be tailored based on the size and shape of the aneurysm being treated. The length L can be approximately 1 inch in length.


During delivery through the microcatheter 600, the detachment feature 150 can be attached to a delivery system at a proximal end of the implant 100, the pinched end 112 can be positioned near the proximal end of the implant 100, and the open end 114 can define the distal end of the implant 100. Collapsing the braid 110 to a single layer tube can result in a braid 110 that has a sufficiently small diameter and a sufficiently short length L to mitigate effects of friction force on the braid 110 when it is delivered through the microcatheter, allowing the braid 110 to be delivered unsheathed in some applications


As illustrated in FIG. 2B, the implant 100 can be delivered to an aneurysm 10 through the microcatheter 600. The open end 114 can be positioned to exit the microcatheter 600 before any other portion of the braid 110 exits the microcatheter. The open end 114 can expand within the aneurysm sac 12 as it exits the microcatheter 600. The illustrated aneurysm 10 is positioned at a bifurcation including a stem blood vessel 700 and two branch vessels 702, and the microcatheter 600 is illustrated being delivered through the stem blood vessel 700. It is contemplated that the implant could be delivered to an aneurysm on a sidewall of a blood vessel through a curved microcatheter, and such a procedure is intended to be embraced by the scope of the present disclosure. As illustrated in FIG. 2C, the distal portion of the braid 110 can continue to expand radially within the aneurysm sac 12 as it exits the microcatheter 600. As the braid 110 is further pushed distally from the microcatheter 600, the braid 110 can appose the aneurysm wall 14 and conform approximate the aneurysm neck 16. The aneurysm 10 being treated can have a diameter that is less than the outer diameter of the tubular braid 110 in the predetermined shape so that the braid 110 tends to expand outwardly, providing a force against the aneurysm wall 14 and sealing approximate the perimeter of the aneurysm neck 16.


As illustrated in FIG. 2D, the braid 110 can form the proximal inversion 122a defining the first segment 142a as the braid 110 is further pushed out of the microcatheter 600. The proximal inversion 122a can be positioned approximate the aneurysm neck 16. The distal inversion 124a defining the second segment 144a can also begin to form as the braid 110 is pushed out of the microcatheter 600. As illustrated in FIGS. 2E through 2F, the “S” shape of the second segment 144a can begin to form as the braid 110 is further pushed from the microcatheter 600.


As illustrated in FIG. 2G, once the first portion of the braid 110, which can comprise the first segment 142a, second segment 144a, and third segment 146a, is in place within the aneurysm sac 12, the fourth segment 152a can radially expand outside the aneurysm 10 as the distal portion of the braid 110 continues to exit the microcatheter 600.


As illustrated in FIG. 2H, the fourth segment 152a can then be compressed distally as it continues to radially expand, compressing the fourth segment 152a up into the first portion of the braid 110.


Finally, as illustrated in FIG. 2I, the fourth segment 152a can be compressed distally into the first portion of the braid 110, at least partially occluding the neck 16 of the aneurysm 10 and the neck opening 126. The pinched end 112 and/or the detachment point 150 can remain external to the aneurysm sac once the fourth segment 152a has reached its final expanded and compressed state. The fourth segment 152a when compressed can be compressed to a minimal thickness as to not become an obstruction to the surrounding blood vessels.


Before the implant 100 is released from the delivery system, the implant 100 can be partially or fully retracted into the microcatheter 600 and repositioned.



FIG. 3A is a flow diagram for a method 300 for forming an occlusive device to treat an aneurysm 10. Step 310 includes selecting an implant comprising a tubular braid, an open end, and a pinched end. Step 320 includes shaping the tubular braid to a predetermined shape, such as the one illustrated in FIG. 1A. As illustrated in FIG. 3B, step 320 can further comprise additional steps. Step 322 includes inverting the tubular braid to form a distal inversion. Step 324 inverts the tubular braid to form a proximal inversion by moving the open end over at least a portion of the braid. Step 326 includes shaping a first segment of the tubular braid extending between the open end and the proximal inversion. Step 328 shapes a second segment of the tubular braid extending between the proximal inversion and the distal inversion. Step 330 includes positioning the open end to encircle the second segment. Step 332 shapes a third segment extending from the distal inversion to the proximal inversion. Step 334 includes positioning the second segment to surround the third segment. Step 336 shapes a fourth segment of the tubular braid extending from the third segment radially outward from a central axis to cross the proximal inversion, fold inwardly toward the central axis, and converge at the pinched end. Step 338 includes positioning the fourth segment approximate a neck of an aneurysm.


In method 300, step 320 of shaping the tubular braid to the predetermined shape can further include shaping the fourth segment to comprise a diameter greater than or approximately equal to a maximum diameter of the first segment. In method 300, the step 320 of shaping the tubular braid to the predetermined shape can further include shaping the fourth segment to a diameter lesser than a maximum diameter of the first segment. The method 300 can further include shaping the tubular braided implant to a delivery shape sized to traverse a lumen of a microcatheter.



FIG. 4A is a flow diagram for a method 400 for a method for treating an aneurysm 10. Step 410 positions a first portion of a tubular braided implant, the tubular braided implant comprising a tubular braid, an open end, and a pinched end, within a sac of the aneurysm such that the first portion circumferentially apposes walls within the sac. The first portion can include one or more inversions. Step 420 includes expanding a second portion of the tubular braided implant radially to occlude a majority of a neck of the aneurysm. Step 430 presses the second portion distally into the first portion. Pressing the second portion distally into the first portion can create three layers of braid at the neck of the aneurysm. The second portion can cover any spatial gaps between the first portion and the aneurysm neck, and can potentially increase metal coverage, decrease porosity of the implant, and increase stasis and blood flow diversion at the neck of the aneurysm to promote the sealing and healing of the aneurysm. Step 440 includes moving the first portion of the tubular braided implant toward a distal portion of the aneurysm wall as a result of pressing the second portion distally into the first portion.


As illustrated in FIG. 4B, step 420 can further include step 422, which includes positioning a fold in the second segment to define a substantially circular perimeter of the second portion. Step 420 can additionally, or alternatively include step 424, which includes compressing the second portion along a central axis of the tubular braided implant such that the second portion comprises a substantially circular shape having an area and the second portion comprises two layers of braid over a majority of the area of the substantially circular shape.


Step 410 can further include shaping the tubular braided implant to form a columnar post encircling a central axis of the tubular braided implant and extending a majority of a height of the first portion. Step 410 can further include positioning a proximal inversion in the first portion of the tubular braided implant approximate the neck of an aneurysm and positioning a distal inversion in the first portion of the tubular braided implant approximate the distal portion of the aneurysm wall. Step 410 can further include positioning the open end of the tubular braided implant to circumferentially appose the aneurysm wall, shaping a first segment of the tubular braid extending between the open end and the proximal inversion to appose an at least a portion of a wall of the aneurysm within the aneurysm's sac, and shaping a second segment of the tubular braid such that the first segment provides an outwardly radial force in a plane defining a boundary between the aneurysm and blood vessel branches, the force sufficient to appose the first segment to walls of the aneurysm.


Step 430 can further include pressing the second portion of the tubular braided implant against the proximal inversion in the first portion of the tubular braided implant. Step 440 can further include moving the distal inversion in the first portion of the tubular braided implant toward the distal portion of the aneurysm wall.


The method 400 can further include shaping the tubular braided implant to form a columnar post encircling a central axis of the tubular braided implant and extending a majority of a height of the first portion. The method 400 can further include retracting the tubular braid until a desired position is achieved relative to the aneurysm. The method 400 can further comprise shaping the tubular braided implant to a delivery shape sized to traverse a lumen of a microcatheter.


As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein.


The descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention. The invention contemplates many variations and modifications of the implant, including: alternative delivery methods, alternative braid materials, alternative means for achieving a desired stiffness/flexibility of braid material, additional structures affixed to the implant (e.g. to aid in anchoring the implant, blood flow diversion, embolism formation, etc.), alternative predetermined braid shapes (e.g. one inversion, three inversions, four inversions, five or more inversions, non-radially symmetric shapes, alternative segment shapes, etc.), alternative implanted shapes, etc. The invention contemplates many variations and modifications to constructing the implant to include combinations of the aforementioned variations and modifications of the implant. The invention contemplates many variations and modifications of implanting the implant to accommodate combinations of the aforementioned variations and modifications of the implant. Modifications apparent to one of ordinary skill in the art following the teachings of this disclosure are intended to be within the scope of the claims which follow.

Claims
  • 1. An implant comprising: a tubular braid comprising an open end and a pinched end, the tubular braid further comprising a predetermined shape in which the tubular braid comprises:a first segment extending from the open end to a proximal inversion,a second segment encircled by the open end and extending from the proximal inversion to a distal inversion,a third segment surrounded by the second segment and extending from the distal inversion to the proximal inversion, anda fourth segment partially encircled by the proximal inversion and extending from the third segment radially outward from a central axis to cross the proximal inversion, fold, and converge at the pinched end.
  • 2. The implant of claim 1, wherein, when the tubular braid is in the predetermined shape, the fourth segment comprises a diameter greater than or approximately equal to a maximum diameter of the first segment.
  • 3. The implant of claim 1, wherein, when the tubular braid is in the predetermined shape, the fourth segment comprises a diameter lesser than a maximum diameter of the first segment.
  • 4. The implant of claim 1, wherein, when the tubular braid is implanted in an aneurysm, the fourth segment occludes at least a portion of an aneurysm neck.
  • 5. The implant of claim 1, wherein, when the tubular braid is in the predetermined shape, the second segment forms a sack, at least a portion of the third segment is positioned within the sack, and at least a portion of the fourth segment is positioned external to the sack.
  • 6. The implant of claim 1, the tubular braid further comprising an implanted shape constrained by an aneurysm, in which the tubular braid comprises: an outer layer corresponding to the first segment of the predetermined shape and positioned to contact an aneurysm wall of the aneurysm,a proximal inversion corresponding to the proximal inversion of the predetermined shape and positioned to be placed approximate an aneurysm neck of the aneurysm, anda sack corresponding to the second segment of the predetermined shape and positioned to appose a portion of the aneurysm wall of the aneurysm and apposing the outer layer.
  • 7. The implant of claim 6, wherein, when the tubular braid is in the implanted shape, the fourth segment comprises a diameter greater than or approximately equal to a maximum diameter of the first segment.
  • 8. The implant of claim 6, wherein, when the tubular braid is in the implanted shape, the fourth segment comprises a diameter lesser than a maximum diameter of the first segment.
  • 9. The implant of claim 6, wherein, when the tubular braid is in the implanted shape, the fourth segment occludes at least a portion of an aneurysm neck.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Continuation-In-Part to U.S. application Ser. No. 16/418,199 filed May 21, 2019, and this application in incorporated herein in its entirety.

US Referenced Citations (424)
Number Name Date Kind
2849002 Oddo Aug 1958 A
3480017 Shute Nov 1969 A
4085757 Pevsner Apr 1978 A
4282875 Serbinenko et al. Apr 1981 A
4364392 Strother et al. Dec 1982 A
4395806 Wonder et al. Aug 1983 A
4517979 Pecenka May 1985 A
4545367 Tucci Oct 1985 A
4836204 Landymore et al. Jun 1989 A
4991602 Amplatz et al. Feb 1991 A
5002556 Ishida et al. Mar 1991 A
5025060 Yabuta et al. Jun 1991 A
5065772 Cox, Jr. Nov 1991 A
5067489 Lind Nov 1991 A
5122136 Guglielmi et al. Jun 1992 A
5192301 Kamiya et al. Mar 1993 A
5261916 Engelson Nov 1993 A
5304195 Twyford, Jr. et al. Apr 1994 A
5334210 Gianturco Aug 1994 A
5350397 Palermo Sep 1994 A
5423829 Pham et al. Jun 1995 A
5624449 Pham et al. Apr 1997 A
5645558 Horton Jul 1997 A
5733294 Forber et al. Mar 1998 A
5891128 Gia et al. Apr 1999 A
5916235 Guglielmi Jun 1999 A
5928260 Chin et al. Jul 1999 A
5935148 Villar Aug 1999 A
5941249 Maynard Aug 1999 A
5951599 McCrory Sep 1999 A
5964797 Ho Oct 1999 A
6007573 Wallace et al. Dec 1999 A
6024756 Pham Feb 2000 A
6036720 Abrams Mar 2000 A
6063070 Eder May 2000 A
6063100 Diaz et al. May 2000 A
6063104 Villar May 2000 A
6080191 Thaler Jun 2000 A
6086577 Ken et al. Jul 2000 A
6096021 Helm et al. Aug 2000 A
6113609 Adams Sep 2000 A
6123714 Gia et al. Sep 2000 A
6168615 Ken Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6193708 Ken et al. Feb 2001 B1
6221086 Forber Apr 2001 B1
6270515 Linden et al. Aug 2001 B1
6315787 Tsugita et al. Nov 2001 B1
6331184 Abrams Dec 2001 B1
6334048 Edvardsson et al. Dec 2001 B1
6346117 Greenhalgh Feb 2002 B1
6350270 Roue Feb 2002 B1
6375606 Garbaldi et al. Apr 2002 B1
6375668 Gifford Apr 2002 B1
6379329 Naglreiter et al. Apr 2002 B1
6391037 Greenhalgh May 2002 B1
6419686 McLeod et al. Jul 2002 B1
6428558 Jones Aug 2002 B1
6454780 Wallace Sep 2002 B1
6463317 Kucharczyk et al. Oct 2002 B1
6506204 Mazzocchi et al. Jan 2003 B2
6527919 Roth Mar 2003 B1
6547804 Porter et al. Apr 2003 B2
6551303 Van Tassel et al. Apr 2003 B1
6569179 Teoh May 2003 B2
6569190 Whalen, II et al. May 2003 B2
6572628 Dominguez Jun 2003 B2
6589230 Gia et al. Jul 2003 B2
6589256 Forber Jul 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6620152 Guglielmi Sep 2003 B2
6669719 Wallace et al. Dec 2003 B2
6689159 Lau et al. Feb 2004 B2
6746468 Sepetka Jun 2004 B1
6780196 Chin et al. Aug 2004 B2
6802851 Jones Oct 2004 B2
6811560 Jones Nov 2004 B2
6833003 Jones et al. Dec 2004 B2
6846316 Abrams Jan 2005 B2
6849081 Sepetka et al. Feb 2005 B2
6855154 Abdel-Gawwad Feb 2005 B2
6949116 Solymar et al. Sep 2005 B2
6964657 Cragg et al. Nov 2005 B2
6964671 Cheng Nov 2005 B2
6994711 Hieshima et al. Feb 2006 B2
7044134 Khairkhahan et al. May 2006 B2
7083632 Avellanet Aug 2006 B2
7093527 Rapaport et al. Aug 2006 B2
7128736 Abrams et al. Oct 2006 B1
7152605 Khairkhahan et al. Dec 2006 B2
7153323 Teoh Dec 2006 B1
7195636 Avellanet et al. Mar 2007 B2
7229454 Tran et al. Jun 2007 B2
7229461 Chin et al. Jun 2007 B2
7309345 Wallace Dec 2007 B2
7371249 Douk et al. May 2008 B2
7377932 Mitelberg et al. May 2008 B2
7410482 Murphy et al. Aug 2008 B2
7572288 Cox Aug 2009 B2
7597704 Frazier et al. Oct 2009 B2
7608088 Jones Oct 2009 B2
7695488 Berenstein et al. Apr 2010 B2
7713264 Murphy May 2010 B2
7744652 Morsi Jun 2010 B2
7892248 Tran Feb 2011 B2
7985238 Balgobin et al. Jul 2011 B2
RE42758 Ken Sep 2011 E
8016852 Ho Sep 2011 B2
8021416 Abrams Sep 2011 B2
8025668 McCartney Sep 2011 B2
8034061 Amplatz et al. Oct 2011 B2
3048145 Evans et al. Nov 2011 A1
8062325 Mitelberg et al. Nov 2011 B2
8075585 Lee et al. Dec 2011 B2
8142456 Rosqueta et al. Mar 2012 B2
8221483 Ford et al. Jul 2012 B2
8261648 Marchand et al. Sep 2012 B1
8267923 Murphy Sep 2012 B2
8361106 Solar et al. Jan 2013 B2
8361138 Adams Jan 2013 B2
8372114 Hines Feb 2013 B2
8398671 Chen Mar 2013 B2
8430012 Marchand Apr 2013 B1
8454633 Amplatz et al. Jun 2013 B2
8523897 Van Der Burg et al. Sep 2013 B2
8523902 Heaven et al. Sep 2013 B2
8551132 Eskridge et al. Oct 2013 B2
8777974 Amplatz et al. Jul 2014 B2
8900304 Alobaid Dec 2014 B1
8974512 Aboytes et al. Mar 2015 B2
8992568 Duggal et al. Mar 2015 B2
8998947 Aboytes et al. Apr 2015 B2
9055948 Jaeger et al. Jun 2015 B2
9107670 Hannes Aug 2015 B2
9161758 Figulla et al. Oct 2015 B2
9232992 Heidner et al. Jan 2016 B2
9259337 Cox et al. Feb 2016 B2
9314326 Wallace et al. Apr 2016 B2
9351715 Mach May 2016 B2
9414842 Glimsdale et al. Aug 2016 B2
9526813 Cohn et al. Dec 2016 B2
9532792 Galdonik et al. Jan 2017 B2
9532873 Kelley Jan 2017 B2
9533344 Monetti et al. Jan 2017 B2
9539011 Chen et al. Jan 2017 B2
9539022 Bowman Jan 2017 B2
9539122 Burke et al. Jan 2017 B2
9539382 Nelson Jan 2017 B2
9549830 Bruszewski et al. Jan 2017 B2
9554805 Tompkins et al. Jan 2017 B2
9561096 Kim et al. Feb 2017 B2
9561125 Bowman et al. Feb 2017 B2
9572982 Burnes et al. Feb 2017 B2
9579104 Beckham et al. Feb 2017 B2
9579484 Barnell Feb 2017 B2
9585642 Dinsmoor et al. Mar 2017 B2
9585669 Becking et al. Mar 2017 B2
9615832 Bose et al. Apr 2017 B2
9615951 Bennett et al. Apr 2017 B2
9622753 Cox Apr 2017 B2
9629635 Hewitt et al. Apr 2017 B2
9636115 Henry et al. May 2017 B2
9636439 Chu et al. May 2017 B2
9642675 Werneth et al. May 2017 B2
9655633 Leynov et al. May 2017 B2
9655645 Staunton May 2017 B2
9655989 Cruise et al. May 2017 B2
9662129 Galdonik et al. May 2017 B2
9662238 Dwork et al. May 2017 B2
9662425 Lilja et al. May 2017 B2
9668898 Wong Jun 2017 B2
9675477 Thompson Jun 2017 B2
9675782 Connolly Jun 2017 B2
9676022 Ensign Jun 2017 B2
9681861 Heisel et al. Jun 2017 B2
9692557 Murphy Jun 2017 B2
9693852 Lam et al. Jul 2017 B2
9700262 Janik et al. Jul 2017 B2
9700399 Acosta-Acevedo Jul 2017 B2
9717421 Griswold et al. Aug 2017 B2
9717500 Tieu et al. Aug 2017 B2
9717502 Teoh et al. Aug 2017 B2
9724103 Cruise et al. Aug 2017 B2
9724526 Strother et al. Aug 2017 B2
9750565 Bloom et al. Sep 2017 B2
9757260 Greenan Sep 2017 B2
9764111 Gulachenski Sep 2017 B2
9770251 Bowman et al. Sep 2017 B2
9770577 Li Sep 2017 B2
9775621 Tompkins et al. Oct 2017 B2
9775706 Paterson et al. Oct 2017 B2
9775732 Khenansho Oct 2017 B2
9788800 Mayoras, Jr. Oct 2017 B2
9795391 Saatchi et al. Oct 2017 B2
9801980 Karino et al. Oct 2017 B2
9808599 Bowman et al. Nov 2017 B2
9833252 Sepetka et al. Dec 2017 B2
9833604 Lam et al. Dec 2017 B2
9833625 Waldhauser et al. Dec 2017 B2
9918720 Marchand et al. Mar 2018 B2
9955976 Hewitt et al. May 2018 B2
10004510 Gerberding Jun 2018 B2
10130372 Griffin Nov 2018 B2
10307148 Heisel et al. Jun 2019 B2
10327781 Divino et al. Jun 2019 B2
10342546 Sepetka et al. Jul 2019 B2
10517604 Bowman et al. Dec 2019 B2
10653425 Gorochow et al. May 2020 B1
10716573 Connor Jul 2020 B2
20020068974 Kuslich et al. Jun 2002 A1
20020082638 Porter et al. Jun 2002 A1
20020143349 Gifford, III et al. Oct 2002 A1
20020147497 Belef et al. Oct 2002 A1
20020188314 Anderson et al. Dec 2002 A1
20030028209 Teoh et al. Feb 2003 A1
20030120337 Van Tassel et al. Jun 2003 A1
20030171739 Murphy et al. Sep 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030181927 Wallace Sep 2003 A1
20030181945 Opolski Sep 2003 A1
20030195553 Wallace et al. Oct 2003 A1
20030216772 Konya Nov 2003 A1
20040034366 van der Burg et al. Feb 2004 A1
20040034386 Fulton et al. Feb 2004 A1
20040044391 Porter Mar 2004 A1
20040087998 Lee et al. May 2004 A1
20040098027 Teoh et al. May 2004 A1
20040127935 Van Tassel et al. Jul 2004 A1
20040133222 Tran et al. Jul 2004 A1
20040153120 Seifert et al. Aug 2004 A1
20040210297 Lin et al. Oct 2004 A1
20040254594 Alfaro Dec 2004 A1
20050021016 Malecki et al. Jan 2005 A1
20050021072 Wallace Jan 2005 A1
20050159771 Petersen Jul 2005 A1
20050177103 Hunter et al. Aug 2005 A1
20050251200 Porter Nov 2005 A1
20060052816 Bates et al. Mar 2006 A1
20060058735 Lesh Mar 2006 A1
20060064151 Guterman et al. Mar 2006 A1
20060106421 Teoh May 2006 A1
20060155323 Porter et al. Jul 2006 A1
20060155367 Hines Jul 2006 A1
20060167494 Suddaby Jul 2006 A1
20060247572 McCartney Nov 2006 A1
20070088387 Eskridge et al. Apr 2007 A1
20070106311 Wallace et al. May 2007 A1
20070208376 Meng Jun 2007 A1
20070162071 Burkett et al. Jul 2007 A1
20070167876 Euteneuer et al. Jul 2007 A1
20070173928 Morsi Jul 2007 A1
20070186933 Domingo Aug 2007 A1
20070191884 Eskridge et al. Aug 2007 A1
20070233188 Hunt et al. Oct 2007 A1
20070265656 Amplatz et al. Nov 2007 A1
20070288083 Hines Dec 2007 A1
20080097495 Feller, III et al. Apr 2008 A1
20080103505 Fransen May 2008 A1
20080119886 Greenhalgh et al. May 2008 A1
20080281350 Sepetka et al. Nov 2008 A1
20090036877 Nardone et al. Feb 2009 A1
20090062841 Amplatz et al. Mar 2009 A1
20090099647 Glimsdale Apr 2009 A1
20090227983 Griffin et al. Sep 2009 A1
20090281557 Sander et al. Nov 2009 A1
20090287291 Becking et al. Nov 2009 A1
20090287294 Rosqueta et al. Nov 2009 A1
20090287297 Cox Nov 2009 A1
20090318941 Sepetka Dec 2009 A1
20100023046 Heidner et al. Jan 2010 A1
20100023048 Mach Jan 2010 A1
20100063573 Hijlkema Mar 2010 A1
20100063582 Rudakov Mar 2010 A1
20100069948 Veznedaroglu et al. Mar 2010 A1
20100168781 Berenstein Jul 2010 A1
20100211156 Linder et al. Aug 2010 A1
20100324649 Mattsson et al. Dec 2010 A1
20110046658 Conner et al. Feb 2011 A1
20110054519 Neuss Mar 2011 A1
20110112588 Linderman et al. May 2011 A1
20110137317 O'Halloran et al. Jun 2011 A1
20110152993 Marchand et al. Jun 2011 A1
20110196413 Wallace Aug 2011 A1
20110319978 Schaffer Dec 2011 A1
20120010644 Sideris et al. Jan 2012 A1
20120071911 Sadasivan Mar 2012 A1
20120165732 Müller Jun 2012 A1
20120191123 Brister et al. Jul 2012 A1
20120283768 Cox et al. Nov 2012 A1
20120310270 Murphy Dec 2012 A1
20120323267 Ren Dec 2012 A1
20120330341 Becking et al. Dec 2012 A1
20130035665 Chu Feb 2013 A1
20130035712 Theobald et al. Feb 2013 A1
20130066357 Aboytes et al. Mar 2013 A1
20130079864 Boden Mar 2013 A1
20130110066 Sharma et al. May 2013 A1
20130204351 Cox et al. Aug 2013 A1
20130211495 Halden et al. Aug 2013 A1
20130261658 Lorenzo et al. Oct 2013 A1
20130261730 Bose et al. Oct 2013 A1
20130274863 Cox et al. Oct 2013 A1
20130345738 Eskridge Dec 2013 A1
20140005714 Quick et al. Jan 2014 A1
20140012307 Franano et al. Jan 2014 A1
20140012363 Franano et al. Jan 2014 A1
20140018838 Franano et al. Jan 2014 A1
20140135812 Divino et al. May 2014 A1
20140200607 Sepetka et al. Jul 2014 A1
20140257360 Keillor Sep 2014 A1
20140257361 Prom Sep 2014 A1
20140277013 Sepetka et al. Sep 2014 A1
20140358178 Hewitt et al. Dec 2014 A1
20150057703 Ryan et al. Feb 2015 A1
20150209050 Aboytes et al. Jul 2015 A1
20150272589 Lorenzo Oct 2015 A1
20150313605 Griffin Nov 2015 A1
20150342613 Aboytes et al. Dec 2015 A1
20150374483 Janardhan et al. Dec 2015 A1
20160022445 Ruvalcaba et al. Jan 2016 A1
20160030050 Franano et al. Feb 2016 A1
20160192912 Kassab et al. Jul 2016 A1
20160249934 Hewitt et al. Sep 2016 A1
20160249935 Hewitt et al. Sep 2016 A1
20170007264 Cruise et al. Jan 2017 A1
20170007265 Guo et al. Jan 2017 A1
20170020670 Murray et al. Jan 2017 A1
20170020700 Bienvenu et al. Jan 2017 A1
20170027640 Kunis et al. Feb 2017 A1
20170027692 Bonhoeffer et al. Feb 2017 A1
20170027725 Argentine Feb 2017 A1
20170035436 Morita Feb 2017 A1
20170035567 Duffy Feb 2017 A1
20170042548 Lam Feb 2017 A1
20170049596 Schabert Feb 2017 A1
20170071737 Kelley Mar 2017 A1
20170072452 Monetti et al. Mar 2017 A1
20170079661 Bardsley et al. Mar 2017 A1
20170079662 Rhee et al. Mar 2017 A1
20170079671 Morero et al. Mar 2017 A1
20170079680 Bowman Mar 2017 A1
20170079717 Walsh et al. Mar 2017 A1
20170079766 Wang et al. Mar 2017 A1
20170079767 Leon-Yip Mar 2017 A1
20170079812 Lam et al. Mar 2017 A1
20170079817 Sepetka et al. Mar 2017 A1
20170079819 Pung et al. Mar 2017 A1
20170079820 Lam et al. Mar 2017 A1
20170086851 Wallace et al. Mar 2017 A1
20170086996 Peterson et al. Mar 2017 A1
20170095259 Tompkins et al. Apr 2017 A1
20170100126 Bowman et al. Apr 2017 A1
20170100141 Morero et al. Apr 2017 A1
20170100143 Granfield Apr 2017 A1
20170100183 Iaizzo et al. Apr 2017 A1
20170113023 Steingisser et al. Apr 2017 A1
20170114350 dos Santos et al. Apr 2017 A1
20170147765 Mehta May 2017 A1
20170151032 Loisel Jun 2017 A1
20170165062 Rothstein Jun 2017 A1
20170165065 Rothstein et al. Jun 2017 A1
20170165454 Tuohy et al. Jun 2017 A1
20170172581 Bose et al. Jun 2017 A1
20170172766 Vong et al. Jun 2017 A1
20170172772 Khenansho Jun 2017 A1
20170189033 Sepetka et al. Jul 2017 A1
20170189035 Porter Jul 2017 A1
20170215902 Leynov et al. Aug 2017 A1
20170216484 Cruise et al. Aug 2017 A1
20170224350 Shimizu et al. Aug 2017 A1
20170224355 Bowman et al. Aug 2017 A1
20170224467 Piccagli et al. Aug 2017 A1
20170224511 Dwork et al. Aug 2017 A1
20170224953 Tran et al. Aug 2017 A1
20170231749 Perkins et al. Aug 2017 A1
20170252064 Staunton Sep 2017 A1
20170265983 Lam et al. Sep 2017 A1
20170281192 Tieu et al. Oct 2017 A1
20170281331 Perkins et al. Oct 2017 A1
20170281344 Costello Oct 2017 A1
20170281909 Northrop et al. Oct 2017 A1
20170281912 Melder et al. Oct 2017 A1
20170290593 Cruise et al. Oct 2017 A1
20170290654 Sethna Oct 2017 A1
20170296324 Argentine Oct 2017 A1
20170296325 Marrocco et al. Oct 2017 A1
20170303939 Greenhalgh et al. Oct 2017 A1
20170303942 Greenhalgh et al. Oct 2017 A1
20170303947 Greenhalgh et al. Oct 2017 A1
20170303948 Wallace et al. Oct 2017 A1
20170304041 Argentine Oct 2017 A1
20170304097 Corwin et al. Oct 2017 A1
20170304595 Nagasrinivasa et al. Oct 2017 A1
20170312109 Le Nov 2017 A1
20170312484 Shipley et al. Nov 2017 A1
20170316561 Helm et al. Nov 2017 A1
20170319826 Bowman et al. Nov 2017 A1
20170333228 Orth et al. Nov 2017 A1
20170333236 Greenan Nov 2017 A1
20170333678 Bowman et al. Nov 2017 A1
20170340333 Badruddin et al. Nov 2017 A1
20170340383 Bloom et al. Nov 2017 A1
20170348014 Wallace et al. Dec 2017 A1
20170348514 Guyon et al. Dec 2017 A1
20180140305 Connor May 2018 A1
20180206850 Wang et al. Jul 2018 A1
20180242979 Lorenzo Aug 2018 A1
20180303531 Sanders et al. Oct 2018 A1
20180338767 Dasnurkar et al. Nov 2018 A1
20190008522 Lorenzo Jan 2019 A1
20190223878 Lorenzo et al. Jan 2019 A1
20190110796 Jayaraman Apr 2019 A1
20190142567 Janardhan et al. May 2019 A1
20190192162 Lorenzo Jun 2019 A1
20190192167 Lorenzo Jun 2019 A1
20190192168 Lorenzo Jun 2019 A1
20190223879 Jayaraman Jul 2019 A1
20190223881 Hewitt et al. Sep 2019 A1
20190328398 Lorenzo Oct 2019 A1
20190357914 Gorochow et al. Nov 2019 A1
20190365385 Gorochow Dec 2019 A1
20200000477 Nita et al. Jan 2020 A1
20200069313 Xu et al. Mar 2020 A1
20200268365 Hebert et al. Aug 2020 A1
Foreign Referenced Citations (98)
Number Date Country
2395796 Jul 2001 CA
2 431 594 Sep 2002 CA
2598048 May 2008 CA
204 683 687 Jul 2015 CN
102008015781 Oct 2009 DE
102010053111 Jun 2012 DE
102009058132 Jul 2014 DE
10 2013 106031 Dec 2014 DE
202008018523 Apr 2015 DE
102011102955 May 2018 DE
902704 Mar 1999 EP
1054635 Nov 2000 EP
1295563 Mar 2003 EP
1441649 Aug 2004 EP
1483009 Dec 2004 EP
1527753 May 2005 EP
1569565 Sep 2005 EP
1574169 Sep 2005 EP
1494619 Jan 2006 EP
1633275 Mar 2006 EP
1659988 May 2006 EP
1725185 Nov 2006 EP
1862122 Dec 2007 EP
1923005 May 2008 EP
2063791 Jun 2009 EP
2134263 Dec 2009 EP
2157937 Mar 2010 EP
2266456 Dec 2010 EP
2324775 May 2011 EP
2367482 Sep 2011 EP
2387951 Nov 2011 EP
2460476 Jun 2012 EP
2468349 Jun 2012 EP
2543345 Jan 2013 EP
2567663 Mar 2013 EP
2617386 Jul 2013 EP
2623039 Aug 2013 EP
2647343 Oct 2013 EP
2848211 Mar 2015 EP
2854704 Apr 2015 EP
2923674 Sep 2015 EP
2926744 Oct 2015 EP
3146916 Mar 2017 EP
3501429 Jun 2019 EP
3517055 Jul 2019 EP
H04-47415 Apr 1992 JP
H07-37200 Jul 1995 JP
2006-509578 Mar 2006 JP
2013-509972 Mar 2013 JP
2013537069 Sep 2013 JP
2014-522268 Sep 2014 JP
2016-502925 Feb 2016 JP
WO 9641589 Dec 1996 WO
WO 9905977 Feb 1999 WO
WO 9908607 Feb 1999 WO
WO 9930640 Jun 1999 WO
WO 2003073961 Sep 2003 WO
WO 03086240 Oct 2003 WO
WO 2005020822 Mar 2005 WO
WO 2005074814 Aug 2005 WO
2005117718 Dec 2005 WO
WO 2006034149 Mar 2006 WO
WO 2006052322 May 2006 WO
2007076480 Jul 2007 WO
WO 2008150346 Dec 2008 WO
WO 2008151204 Dec 2008 WO
WO 2009048700 Apr 2009 WO
WO 2009105365 Aug 2009 WO
WO 2009132045 Oct 2009 WO
WO 2009135166 Nov 2009 WO
WO 2010030991 Mar 2010 WO
WO 2011057002 May 2011 WO
WO 2012032030 Mar 2012 WO
WO 2012099704 Jul 2012 WO
WO 2012099909 Jul 2012 WO
WO 2012113554 Aug 2012 WO
WO 2013016618 Jan 2013 WO
WO 2013025711 Feb 2013 WO
WO 2013109309 Jul 2013 WO
WO 2013159065 Oct 2013 WO
WO 2013162817 Oct 2013 WO
WO 2014029835 Feb 2014 WO
WO 2014078286 May 2014 WO
WO 2014110589 Jul 2014 WO
WO 2014137467 Sep 2014 WO
WO 2015073704 May 2015 WO
2015160721 Oct 2015 WO
2015171268 Nov 2015 WO
WO 2015166013 Nov 2015 WO
WO 2015184075 Dec 2015 WO
WO 2015187196 Dec 2015 WO
WO 2016044647 Mar 2016 WO
WO 2016107357 Jul 2016 WO
WO 2016137997 Sep 2016 WO
WO 2017161283 Sep 2017 WO
WO 2018051187 Mar 2018 WO
WO 2019038293 Feb 2019 WO
WO 2012034135 Mar 2021 WO
Non-Patent Literature Citations (7)
Entry
Extended European Search Report issued in corresponding European Patent Application No. 20 21 2968 dated May 11, 2021.
Altes et al., Creation of Saccular Aneurysms in the Rabbit: A Model Suitable for Testing Endovascular Devices AJR 2000; 174: 349-354.
Schaffer, Advanced Materials & Processes, Oct. 2002, pp. 51-54.
Extended European Search Report issued in corresponding European Patent Application No. 19 21 5277 dated May 12, 2020.
File History for corresponding U.S. Appl. No. 15/430,141, filed Feb. 10, 2017 cited by Applicant in parent U.S. Appl. No. 16/418,199.
File History for corresponding U.S. Appl. No. 15/430,419, filed Feb. 10, 2017 cited by Applicant in parent U.S. Appl. No. 16/418,199.
File History for corresponding U.S. Appl. No. 62/293,710, filed Feb. 10, 2017 cited by Applicant in parent U.S. Appl. No. 16/418,199.
Related Publications (1)
Number Date Country
20200367899 A1 Nov 2020 US
Continuation in Parts (1)
Number Date Country
Parent 16418199 May 2019 US
Child 16853135 US